Friday, March 01, 2019 12:25:58 PM
Chris2125 100% $85 4/1/2019
Larrybirdlegend 100% $80 4/1/2019
Profits101 95% $52 2/1/2020
jomama9231 95% $100 12/1/2019
zmanindc 90% $51 10/1/2019
heysfguy 90% $75 5/1/2019
jamesmurphy 89% $38 11/1/2019
shadolane 88% $59 9/1/2019
Mikenac 85% $110 1/1/2021
skrotcha387 85% $87 7/1/2019
FFS 84% $60 3/1/2019
Invest83838 83% $88 8/1/2019
mclim 80% $51 9/1/2019
Cal8 80% $80 6/1/2019
VuBru 80% $45 6/1/2019
MNBioMike 80% $50 6/1/2019
circuitvity 80% $70 3/1/2019
Toddrobertking 77% $68 5/1/2019
Mrmainstreet 75% $45 3/1/2020
louieblouie 75% $57 11/1/2019
BaaBaa45 75% $65 8/1/2019
rapid-runner 75% $115 4/1/2020
best_golfer 75% $100 10/1/2019
jmhill23 70% $55 10/1/2019
rydad21 70% $83 9/1/2019
stockboy 70% $55 9/1/2019
ibew_488 68% $72 8/1/2019
CalMustang 67% $85 12/1/2019
fsulevine 65% $54 11/1/2019
ilovetech 65% $81 11/1/2019
flubber 65% $47 6/1/2019
TastytheElf 60% $60 2/1/2020
dukesking 60% $81 1/1/2020
alwayswatching 60% $80 10/1/2019
HawkDriver 60% $70 8/1/2019
Markipeach 60% $50 7/1/2019
Flounder 50% $62 6/1/2019
AN12345 50% $55 5/1/2019
Hspooner 50% $67 4/1/2019
rafunrafun 50% $77 4/1/2019
Danouse 48% $64 5/1/2019
NI-bound 44% $85 4/1/2020
xblkbk 40% $64 7/1/2019
HerbieRay 10% $100 1/1/2020
Babr 10% $50 9/1/2019
Half the crowd thinks there's a greater than 75% chance of a BO, and half thinks this BO will be higher than $67 a share. Half also think we'll see this before September of this year.
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM